Status:
UNKNOWN
The Becoming of Children With Doose Syndrome
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Collaborating Sponsors:
University Hospital, Lille
University Hospital, Rouen
Conditions:
Doose Syndrome
Epileptic Syndromes
Eligibility:
All Genders
1-6 years
Brief Summary
Doose syndrome is a rare epileptic syndrome that can lead to learning difficulties and a poor quality of life. The goal of this study is to evaluate the evolution of epilepsy and its consequences on c...
Detailed Description
Doose syndrome is a rare epileptic syndrome beginning between ages two and five, characterized by myoclonic-astatic seizures which can be associated with myoclonic seizures, astatic seizures, absences...
Eligibility Criteria
Inclusion
- children with doose syndrome diagnosed between ages 1 and 6
- normal development until onset of seizures
Exclusion
- unconfirmed diagnoses
- abnormal diagnoses
- abnormal psychomotor development before onset of seizures
- cerebral MRI abnormalities
- other child epileptic syndromes
Key Trial Info
Start Date :
August 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04048213
Start Date
August 1 2019
End Date
December 1 2023
Last Update
April 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Amiens
Amiens, France, 80480